Ironwood Pharmaceuticals (IRWD) Share-based Compensation Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 244.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 244.32% |
| Mar 31, 2026 | 60,783.33% |
| Dec 31, 2025 | -16.27% |
| Sep 30, 2025 | -99.99% |
| Jun 30, 2025 | -88.27% |
| Mar 31, 2025 | -99.94% |
| Dec 31, 2024 | 123.66% |
| Sep 30, 2024 | 63,969.23% |
| Jun 30, 2024 | -45.10% |
| Mar 31, 2024 | 517.62% |
| Dec 31, 2023 | -364.66% |
| Sep 30, 2023 | -98.37% |
| Jun 30, 2023 | -68.34% |
| Mar 31, 2023 | 7.10% |
| Dec 31, 2022 | 108.91% |
| Sep 30, 2022 | -87.02% |
| Jun 30, 2022 | -23.92% |
| Mar 31, 2022 | -31.79% |
| Dec 31, 2021 | 232.85% |
| Sep 30, 2021 | -20.46% |